Nayana A Sojin, Rhea Parimoo, Lauren A Agliano, Amie J Goodin, Deepthi S Varma, Bruce A Goldberger, Ibrahim Tuna, Reem Abu-Rustum, Kay Roussos-Ross
{"title":"招募大麻暴露的母婴对进行纵向研究:可行性评估。","authors":"Nayana A Sojin, Rhea Parimoo, Lauren A Agliano, Amie J Goodin, Deepthi S Varma, Bruce A Goldberger, Ibrahim Tuna, Reem Abu-Rustum, Kay Roussos-Ross","doi":"10.3389/fpsyt.2025.1637076","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>In-utero</i> marijuana exposures are correlated with adverse neurodevelopmental outcomes in exposed neonates. As rates of marijuana use in pregnancy and postpartum reportedly increase, it is crucial to obtain conclusive, pregnancy-specific safety data through well-designed clinical research studies. The objective of this study is to assess feasibility of recruitment and retention of marijuana-exposed pregnant women for longitudinal study involving biospecimen and imaging collection.</p><p><strong>Methods: </strong>Participants self-reporting marijuana use in pregnancy and controls with no self-reported exposure were recruited from routine prenatal care in a large health-system. Consented participants completed imaging and biological specimen collections during pregnancy, at delivery, and postpartum. Proportions of collected samples/images at each data collection interval were calculated and compared for exposed versus unexposed.</p><p><strong>Results: </strong>30 participants were recruited over 20 months: 77% (n=23) self-reported as marijuana-exposed and 23% (n=7) reported as unexposed (control). 70% (n=21) of participants completed the study (n=14 marijuana-exposed; n=7 control), while 30% (n=9 marijuana-exposed; 0%, n=0 control) completed some study visits before becoming lost-to-follow-up (LTFU).</p><p><strong>Discussion: </strong>Preliminary findings suggest that it is feasible to recruit and retain pregnant women using marijuana for longitudinal study. Although marijuana-exposed participants were more likely than control participants to miss postpartum visits, become LTFU, and require rescheduling of study visits, marijuana-exposed participants were still found to complete 68% of study visits.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1637076"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463817/pdf/","citationCount":"0","resultStr":"{\"title\":\"Recruiting marijuana-exposed maternal-infant dyads for longitudinal study: a feasibility assessment.\",\"authors\":\"Nayana A Sojin, Rhea Parimoo, Lauren A Agliano, Amie J Goodin, Deepthi S Varma, Bruce A Goldberger, Ibrahim Tuna, Reem Abu-Rustum, Kay Roussos-Ross\",\"doi\":\"10.3389/fpsyt.2025.1637076\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong><i>In-utero</i> marijuana exposures are correlated with adverse neurodevelopmental outcomes in exposed neonates. As rates of marijuana use in pregnancy and postpartum reportedly increase, it is crucial to obtain conclusive, pregnancy-specific safety data through well-designed clinical research studies. The objective of this study is to assess feasibility of recruitment and retention of marijuana-exposed pregnant women for longitudinal study involving biospecimen and imaging collection.</p><p><strong>Methods: </strong>Participants self-reporting marijuana use in pregnancy and controls with no self-reported exposure were recruited from routine prenatal care in a large health-system. Consented participants completed imaging and biological specimen collections during pregnancy, at delivery, and postpartum. Proportions of collected samples/images at each data collection interval were calculated and compared for exposed versus unexposed.</p><p><strong>Results: </strong>30 participants were recruited over 20 months: 77% (n=23) self-reported as marijuana-exposed and 23% (n=7) reported as unexposed (control). 70% (n=21) of participants completed the study (n=14 marijuana-exposed; n=7 control), while 30% (n=9 marijuana-exposed; 0%, n=0 control) completed some study visits before becoming lost-to-follow-up (LTFU).</p><p><strong>Discussion: </strong>Preliminary findings suggest that it is feasible to recruit and retain pregnant women using marijuana for longitudinal study. Although marijuana-exposed participants were more likely than control participants to miss postpartum visits, become LTFU, and require rescheduling of study visits, marijuana-exposed participants were still found to complete 68% of study visits.</p>\",\"PeriodicalId\":12605,\"journal\":{\"name\":\"Frontiers in Psychiatry\",\"volume\":\"16 \",\"pages\":\"1637076\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463817/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fpsyt.2025.1637076\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fpsyt.2025.1637076","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Recruiting marijuana-exposed maternal-infant dyads for longitudinal study: a feasibility assessment.
Introduction: In-utero marijuana exposures are correlated with adverse neurodevelopmental outcomes in exposed neonates. As rates of marijuana use in pregnancy and postpartum reportedly increase, it is crucial to obtain conclusive, pregnancy-specific safety data through well-designed clinical research studies. The objective of this study is to assess feasibility of recruitment and retention of marijuana-exposed pregnant women for longitudinal study involving biospecimen and imaging collection.
Methods: Participants self-reporting marijuana use in pregnancy and controls with no self-reported exposure were recruited from routine prenatal care in a large health-system. Consented participants completed imaging and biological specimen collections during pregnancy, at delivery, and postpartum. Proportions of collected samples/images at each data collection interval were calculated and compared for exposed versus unexposed.
Results: 30 participants were recruited over 20 months: 77% (n=23) self-reported as marijuana-exposed and 23% (n=7) reported as unexposed (control). 70% (n=21) of participants completed the study (n=14 marijuana-exposed; n=7 control), while 30% (n=9 marijuana-exposed; 0%, n=0 control) completed some study visits before becoming lost-to-follow-up (LTFU).
Discussion: Preliminary findings suggest that it is feasible to recruit and retain pregnant women using marijuana for longitudinal study. Although marijuana-exposed participants were more likely than control participants to miss postpartum visits, become LTFU, and require rescheduling of study visits, marijuana-exposed participants were still found to complete 68% of study visits.
期刊介绍:
Frontiers in Psychiatry publishes rigorously peer-reviewed research across a wide spectrum of translational, basic and clinical research. Field Chief Editor Stefan Borgwardt at the University of Basel is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
The journal''s mission is to use translational approaches to improve therapeutic options for mental illness and consequently to improve patient treatment outcomes.